Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lawson, K. A.
Right arrow Articles by Kline, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lawson, K. A.
Right arrow Articles by Kline, K.
Vol. 2, 437-444, May 2003     Molecular Cancer Therapeutics
© 2003 American Association for Cancer Research

Novel Vitamin E Analogue Decreases Syngeneic Mouse Mammary Tumor Burden and Reduces Lung Metastasis1

Karla A. Lawson, Kristen Anderson, Marla Menchaca, Jeffrey Atkinson, LuZhe Sun, Vernon Knight, Brian E. Gilbert, Claudio Conti, Bob G. Sanders and Kimberly Kline2

Division of Nutrition/A2703 [K. A. L., K. K.] and School of Biological Sciences/C0900 [K. A., M. M., B. G. S.] University of Texas at Austin, Austin, Texas 78712; Department of Chemistry, Brock University, St. Catharines, Ontario, L2S 3A1 Canada [J. A.]; Department of Cellular and Structural Biology, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229 [L. Z. S.]; Department of Molecular Physiology and Biophysics [V. K.] and Department of Molecular Virology and Microbiology [B. E. G.], Baylor College of Medicine, Houston, Texas 77030; and University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957 [C. C.]

2 To whom requests for reprints should be addressed, at Division of Nutrition/A2703, University of Texas at Austin, Austin, TX 78712-1097. Phone: (512) 471-8911; Fax: (512) 232-7040; E-mail: k.kline{at}mail.utexas.edu

A nonhydrolyzable ether analogue of RRR-{alpha}-tocopherol, 2,5,7,8-tetramethyl-2R-(4R, 8R, 12-trimethyltridecyl)chroman-6-yloxyacetic acid, called RRR-{alpha}-tocopheryloxyacetic acid or RRR-{alpha}-tocopherol ether-linked acetic acid analogue ({alpha}-TEA), exhibits antitumor activity in vitro and in vivo using a syngeneic BALB/c mouse mammary tumor model (line 66 clone 4 stably transfected with green fluorescent protein). Treatment of cells with 5, 10, and 20 µg/ml {alpha}-TEA for 3 days produced 6, 34, and 50% apoptosis, respectively, and treatment of cells with 10 µg/ml for 2, 3, 4, and 5 days produced 20, 35, 47, and 58% apoptosis, respectively. A liposomal formulation of {alpha}-TEA administered by aerosol reduced s.c. tumor growth and lung metastasis. {alpha}-TEA-treated animals showed a significant decrease in tumor volumes over 17 days of aerosol treatment (P < 0.001). Forty percent of aerosol as well as untreated control mice had visible, macroscopic lung metastases versus none (0%) of the {alpha}-TEA-treated mice. On the basis of fluorescence microscopic examination of the surface (top and bottom) of flattened whole left lung lobes, an average of 60 ± 15 and 102 ± 17 versus 11 ± 4 fluorescent microscopic metastases was observed in aerosol control and untreated control versus {alpha}-TEA-treated animals, respectively. {alpha}-TEA formulated in ethanol + peanut oil (5 mg/mouse/day) delivered by gavage did not reduce s.c. primary tumor burden; however, fluorescent microscopic lung metastases were significantly reduced (P < 0.0021). In summary, {alpha}-TEA formulated in liposomes and delivered by aerosol is a potent antitumor agent and reduces lung metastasis.




This article has been cited by other articles:


Home page
Cancer Res.Home page
T. Hahn, L. Szabo, M. Gold, L. Ramanathapuram, L. H. Hurley, and E. T. Akporiaye
Dietary Administration of the Proapoptotic Vitamin E Analogue {alpha}-Tocopheryloxyacetic Acid Inhibits Metastatic Murine Breast Cancer
Cancer Res., October 1, 2006; 66(19): 9374 - 9378.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Paris and R. Sesboue
Metastasis models: the green fluorescent revolution?
Carcinogenesis, December 1, 2004; 25(12): 2285 - 2292.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. Kline, W. Yu, and B. G. Sanders
Vitamin E and Breast Cancer
J. Nutr., December 1, 2004; 134(12): 3458S - 3462S.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. A. Lawson, K. Anderson, M. Simmons-Menchaca, J. Atkinson, L. Sun, B. G. Sanders, and K. Kline
Comparison of Vitamin E Derivatives {alpha}-TEA and VES in Reduction of Mouse Mammary Tumor Burden and Metastasis
Experimental Biology and Medicine, October 1, 2004; 229(9): 954 - 963.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Anderson, M. Simmons-Menchaca, K. A. Lawson, J. Atkinson, B. G. Sanders, and K. Kline
Differential Response of Human Ovarian Cancer Cells to Induction of Apoptosis by Vitamin E Succinate and Vitamin E Analogue, {alpha}-TEA
Cancer Res., June 15, 2004; 64(12): 4263 - 4269.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.